The top 100 stock
market authors
selected for publication in the last week
market authors
selected for publication in the last week
You are currently following Karuna Kanagaratnam
Stop FollowingYou are no longer following Karuna Kanagaratnam
-
0
)
-
You must have missed the 17-0 vote for safety 13-4 vote for efficacy, as well as the testimonial of the patients who have benefited from provenge.
May 14 16:43 pm
|Rating:
0
0
All Comments by Karuna Kanagaratnam »A Lost Hope? Dendreon Derailed While Archaic FDA Promises 'New Era' [View article]
You must have also missed the fact, that Dendreon has resisted buyouts.
Thank you.